Published in J Am Soc Nephrol on November 11, 2014
Glomerular Aging and Focal Global Glomerulosclerosis: A Podometric Perspective. J Am Soc Nephrol (2015) 1.76
Molecular assessment of disease states in kidney transplant biopsy samples. Nat Rev Nephrol (2016) 0.85
Podometrics as a Potential Clinical Tool for Glomerular Disease Management. Semin Nephrol (2015) 0.83
Relationships among injury, fibrosis, and time in human kidney transplants. JCI Insight (2016) 0.78
Podocyte number and density changes during early human life. Pediatr Nephrol (2016) 0.77
Podocyte Depletion in Thin GBM and Alport Syndrome. PLoS One (2016) 0.77
Quantitative podocyte parameters predict human native kidney and allograft half-lives. JCI Insight (2016) 0.76
Transplant glomerulopathy: the view from the other side of the basement membrane. J Am Soc Nephrol (2014) 0.75
From Patient to Dish and Back Again: Are We There Yet? J Am Soc Nephrol (2015) 0.75
Podocyturia: Potential applications and current limitations. World J Nephrol (2017) 0.75
Accelerated podocyte detachment and progressive podocyte loss from glomeruli with age in Alport Syndrome. Kidney Int (2017) 0.75
The Effect of Cortex/Medulla Proportions on Molecular Diagnoses in Kidney Transplant Biopsies: Rejection and Injury Can Be Assessed in Medulla. Am J Transplant (2017) 0.75
Long-term risks for kidney donors. Kidney Int (2013) 11.90
Risk of end-stage renal disease following live kidney donation. JAMA (2014) 9.63
The Banff 97 working classification of renal allograft pathology. Kidney Int (1999) 9.02
Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant (2007) 5.39
The spectrum of podocytopathies: a unifying view of glomerular diseases. Kidney Int (2007) 5.15
Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest (1997) 4.83
Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene. J Am Soc Nephrol (2005) 4.79
Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant (2014) 3.43
Pathways to nephron loss starting from glomerular diseases-insights from animal models. Kidney Int (2005) 3.09
Identifying specific causes of kidney allograft loss. Am J Transplant (2008) 2.77
Podocyte hypertrophy, "adaptation," and "decompensation" associated with glomerular enlargement and glomerulosclerosis in the aging rat: prevention by calorie restriction. J Am Soc Nephrol (2005) 2.49
Angiotensin II-dependent persistent podocyte loss from destabilized glomeruli causes progression of end stage kidney disease. Kidney Int (2011) 2.28
The impact of body mass index on renal transplant outcomes: a significant independent risk factor for graft failure and patient death. Transplantation (2002) 2.20
Kidney and recipient weight incompatibility reduces long-term graft survival. J Am Soc Nephrol (2010) 2.08
Podocytopenia and disease severity in IgA nephropathy. Kidney Int (2002) 1.98
The clinical importance of nephron mass. J Am Soc Nephrol (2010) 1.94
Angiotensin II blockade in kidney transplant recipients. J Am Soc Nephrol (2013) 1.77
Urine podocyte mRNAs mark progression of renal disease. J Am Soc Nephrol (2009) 1.65
Transplant glomerulopathy may occur in the absence of donor-specific antibody and C4d staining. Clin J Am Soc Nephrol (2007) 1.64
Growth-dependent podocyte failure causes glomerulosclerosis. J Am Soc Nephrol (2012) 1.60
Podocyte is the major culprit accounting for the progression of chronic renal disease. Microsc Res Tech (2002) 1.55
Transplant glomerulopathy, late antibody-mediated rejection and the ABCD tetrad in kidney allograft biopsies for cause. Am J Transplant (2007) 1.44
Influence of obesity on the appearance of proteinuria and renal insufficiency after unilateral nephrectomy. Kidney Int (2000) 1.43
Transplant glomerulopathy: subclinical incidence and association with alloantibody. Am J Transplant (2007) 1.40
Unraveling the role of podocyte turnover in glomerular aging and injury. J Am Soc Nephrol (2014) 1.36
Transplant glomerulopathy. Am J Transplant (2008) 1.29
Significance and management of proteinuria in kidney transplant recipients. J Am Soc Nephrol (2009) 1.27
Urine podocyte mRNAs, proteinuria, and progression in human glomerular diseases. J Am Soc Nephrol (2013) 1.20
Estimating podocyte number and density using a single histologic section. J Am Soc Nephrol (2013) 1.14
Transplant glomerulopathy: ultrastructural abnormalities occur early in longitudinal analysis of protocol biopsies. Am J Transplant (2007) 1.11
Early ultrastructural changes in renal allografts: correlation with antibody-mediated rejection and transplant glomerulopathy. Am J Transplant (2011) 0.98
Clinical evidence on the use of anti-mTOR drugs in renal transplantation. Nefrologia (2011) 0.95
The contribution of podocytes to chronic allograft nephropathy. Nephron Exp Nephrol (2008) 0.93
Change in renal parenchymal volume in living kidney transplant donors. Int Urol Nephrol (2013) 0.93
Mammalian target of rapamycin inhibition prevents glomerular hypertrophy in a model of renal mass reduction. Transplantation (2009) 0.85
Effect of early conversion from CNI to sirolimus on outcomes in kidney transplant recipients with allograft dysfunction. J Nephrol (2012) 0.83
Histology and proteinuria after renal transplantation. Transplant Rev (Orlando) (2012) 0.83
New options and perspectives for proteinuria management after kidney transplantation. Transplant Rev (Orlando) (2012) 0.82
Diminished met signaling in podocytes contributes to the development of podocytopenia in transplant glomerulopathy. Am J Pathol (2011) 0.78
Glomerular Aging and Focal Global Glomerulosclerosis: A Podometric Perspective. J Am Soc Nephrol (2015) 1.76
Estimating podocyte number and density using a single histologic section. J Am Soc Nephrol (2013) 1.14
FSGS as an Adaptive Response to Growth-Induced Podocyte Stress. J Am Soc Nephrol (2017) 0.78